Abstract:Ligand-gated ion channels (LGICs) are involved in many pathophysiological processes and represent a relevant, although challenging, target for drug discovery. The gold standards for studying the ligand-induced ion channel currents and their modulations by drugs are manual patch clamp or two-electrode voltage clamp (TEVC) electrophysiology, but the throughput is low. Higher throughput has been achieved with automated patch clamp instruments, but these have immense acquisition and significant operating costs. In a proof-of-concept study, we developed a reliable, easy to use and multiplexable microfluidic setup to screen the action of drugs at LGICs heterologously expressed in X. laevis oocytes by measuring the electrical impedance changes across the plasma membrane induced by ligand pulses. We validated our setup by simultaneous TEVC electrophysiology and tested the effects of the reference drugs suramin, TNP-ATP, PPADS or diazepam on oocytes expressing P2X2 or GABAAreceptors, respectively. The drugs modulate ATP-induced and GABA-induced currents of P2X2 and GABAA receptors, respectively. The results obtained with TEVC are similar in terms of drug efficacy to those obtained with simultaneously recorded membrane impedances, which are determined by electrical impedance changes. Thus, the study shows the reliability of our setup as a faster (higher throughput) and more cost-effective method for drug screening compared to conventional electrophysiological techniques. After multiplexing of the system, the setup may facilitate commercial and academic drug screening of ligand gated ion channels that are receiving less attention due to limitations in current assays. [Funded under the Excellence Strategy of the Federal Government and the Länder - OPSF671]

An efficient and information-rich biochemical method design for fragment library screening on ion channels

Identification of Small-Molecule Ion Channel Modulators in C. Elegans Channelopathy Models.

Fragment Databases from Screened Ligands for Drug Discovery (FDSL-DD).

Electrical Impedance Spectroscopy for Drug Screening on Ligand-Gated Ion Channels

Fragment-based screening of enzyme drug targets : Microfluidic mobility shift assay improves confidence in candidate selection

Novel screening techniques for ion channel targeting drugs

Targeting ion channels with ultra-large library screening for hit discovery

Ligand Screening of Membrane Proteins Embedded in Nanodiscs: How to Manage Non-Specific Interactions in Weak Affinity Chromatography?

Fragment-Based Computational Method for Designing GPCR Ligands

Mechanism-specific Assay Design Facilitates the Discovery of Nav1.7-selective Inhibitors

Biophysical screening for the discovery of small-molecule ligands

Towards high-resolution modeling of small molecule – ion channel interactions

Optimising experimental designs for model selection of ion channel drug binding mechanisms

High-throughput and Automated Anion Transport Assays

High throughput clone screening on overexpressed hERG1 and Kv1.3 potassium channels using ion channel reader (ICR) label free technology

A Proximity Based General Method for Identification of Ligand and Receptor Interactions in Living Cells.

Identification of selective ligands targeting two GPCRs by receptor-affinity chromatography coupled with high-throughput sequencing techniques

Fluorescence-Based HTS Assays for Ion Channel Modulation in Drug Discovery Pipelines

Computer-Aided Drug Discovery and Design Targeting Ion Channels.

Using Ligand-Induced Conformational Change to Screen for Compounds Targeting G-Protein-Coupled Receptors

A fragment based competitive 19F LB‐NMR platform for hotspot directed ligand profiling